LRRK2 and Parkinson disease: The same year, Botta-Orfila and colleagues [176] analyzed miRNAs in blood serum samples from 10 idiopathic PD (IPD) and 10 familial PD patients carrying the LRRK2 G2019S mutation (LRRK2 PD) vs. 10 controls.